m+Medelevator.RU
← Поиск публикаций
Advances in genetics · 2025

Retrotransposons as both "architects" and "saboteurs" in the nervous system.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Izquierdo-Useros Nuria, Dierssen Mara, Clotet Bonaventura, Elizalde-Torrent Aleix, Carriba Paulina

Аннотация

Transposable elements (TEs), once dismissed as genomic "junk," are now recognized as major forces shaping the architecture, function, and evolution of the nervous system. Among them, retrotransposons-particularly Long Interspersed Nuclear Elements (LINEs) play a dual role as both architects of neuronal diversity and saboteurs of genomic integrity. During neurodevelopment, transient retrotransposon activation contributes to somatic mosaicism, activity-dependent transcription, and synaptic plasticity, thereby enhancing cognitive adaptability. However, the same mechanisms that promote neuronal complexity render the brain vulnerable to aging and disease. Epigenetic erosion during senescence leads to derepression of LINEs and endogenous retroviruses, triggering genomic instability and neuroinflammation through the cGAS-STING pathway. Such "retrotransposon storms" are increasingly linked to neurodegenerative disorders, notably Alzheimer's disease, where tau- and Aβ-driven chromatin relaxation facilitates TE reactivation. The chapter integrates evidence from molecular, cellular, and translational research, highlighting therapeutic opportunities, from reverse transcriptase inhibitors like lamivudine to epigenetic and innate immune modulators, that aim to restore genomic homeostasis. Understanding retrotransposons as both evolutionary catalysts and pathological triggers reframes their role in brain biology and positions them as novel therapeutic targets in aging and neurodegeneration.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты